Volume 19, Issue 1 (Mar-Apr 2011)
JSSU 2011, 19(1): 65-74 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fallahi F, Roghani M, Khalilzad M. Hypoglycemic and Hypolipidemic Effects of Allium Ursinum in Diabetic Rats. JSSU 2011; 19 (1) :65-74
URL: http://jssu.ssu.ac.ir/article-1-1453-en.html
URL: http://jssu.ssu.ac.ir/article-1-1453-en.html
Abstract: (10235 Views)
Introduction: The hypoglycemic and hypolipidemic effects of Allium ursinum(AU) were investigated in an experimental model of diabetes mellitus, invitro.
Methods: Male Wistar rats were divided into control, AU-treated control, diabetic glibenclamide-treated, and AU-treated diabetic groups. For induction of diabetes, streptozocin(STZ) was intraperitoneally administered(60 mg/Kg). AU-treated groups received AU mixed with standard pelleted food at a weight ratio of 1% for 2 months. Serum glucose and lipids levels were determined before the study and at the 4th and 8th week after the study.
Results: Serum glucose was significantly lower in AU-treated diabetic rats at the end of the 4th and 8th weeks(p<0.005 and p<0.01 respectively) as compared to untreated diabetics. Serum total cholesterol, triglyceride, and HDL-cholesterol levels did not show a significant change in AU-treated diabetic rats as compared to untreated diabetics. On the other hand, LDL-cholesterol levels decreased in AU-treated diabetic group as compared to untreated diabetic group(p<0.05).
Conclusion: Oral administration of AU has a significant hypoglycemic effect and in long term leads to decreased levels of serum LDL-cholesterol in diabetic rats.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
